Eyenovia Inc
NASDAQ:EYEN
Eyenovia Inc
Net Issuance of Common Stock
Eyenovia Inc
Net Issuance of Common Stock Peer Comparison
Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors
Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Eyenovia Inc
NASDAQ:EYEN
|
Net Issuance of Common Stock
$16.4m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Net Issuance of Common Stock
$2.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Net Issuance of Common Stock
-$4.9B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-100%
|
CAGR 10-Years
N/A
|
|
Pfizer Inc
NYSE:PFE
|
Net Issuance of Common Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck & Co Inc
NYSE:MRK
|
Net Issuance of Common Stock
-$1.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
34%
|
CAGR 10-Years
14%
|
|
Eli Lilly and Co
NYSE:LLY
|
Net Issuance of Common Stock
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Eyenovia Inc's Net Issuance of Common Stock?
Net Issuance of Common Stock
16.4m
USD
Based on the financial report for Mar 31, 2024, Eyenovia Inc's Net Issuance of Common Stock amounts to 16.4m USD.
What is Eyenovia Inc's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 5Y
37%
Over the last year, the Net Issuance of Common Stock growth was 100%. The average annual Net Issuance of Common Stock growth rates for Eyenovia Inc have been -1% over the past three years , 37% over the past five years .